Fractyl Health (GUTS) Other Non-Current Liabilities (2023 - 2026)
Fractyl Health (GUTS) reported Other Non-Current Liabilities of $569000.0 for Q1 2026, down 38.15% year-on-year from $920000.0 in Q1 2025, and down 14.18% quarter-over-quarter from $663000.0 in Q4 2025.
Fractyl Health (GUTS) has 4 years of Other Non-Current Liabilities data on file, last reported at $569000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities fell 38.15% year-over-year to $569000.0; the trailing twelve-month figure through Mar 2026 stood at $569000.0 (down 38.15% YoY), and the FY2025 full-year result was $663000.0, down 33.57% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $569000.0, down from $663000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.6 million in Q3 2023 and bottomed at $330000.0 in Q1 2024.
- A 4-year average of $970700.0 and a median of $879000.0 in 2025 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities plunged 58.77% in 2024 and jumped 178.79% in 2025, its largest moves.
- Tracing GUTS's Other Non-Current Liabilities over 4 years: stood at $2.6 million in 2023, then sank by 61.62% to $998000.0 in 2024, then sank by 33.57% to $663000.0 in 2025, then dropped by 14.18% to $569000.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $569000.0, $663000.0, and $753000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 569,000.00 |
| Dec 31, 2025 | 663,000.00 |
| Sep 30, 2025 | 753,000.00 |
| Jun 30, 2025 | 838,000.00 |
| Mar 31, 2025 | 920,000.00 |
| Dec 31, 2024 | 998,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 964,000.00 |
| Mar 31, 2024 | 330,000.00 |
| Sep 30, 2023 | 2.60 Mn |